Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alain, Francillon"'
Autor:
Florence Tubach, Véronique Lamarque-Garnier, Anne Castot, Laurent Auclert, Marthe Bonnin, Magda Daudin, Catherine Dubois, Alain Francillon, Elisabeth Frauger, Danièle Girault, Marie-Laurence Gourlay, Pascale Jolliet, Carmen Kreft Jaïs, Lamiae Grimaldi, Michel Lièvre, Patricia Maillère, Philippe Maugendre, Joelle Micallef, Sara Miranda, Antoine Pariente, Sylvie Paulmier Bigot, Jonathan Pentel, Laure Prestat, Fanny Pruvot, Valérie Querol Ferrer, Fanny Rocher, Christel Saussier, Laura Zanetti
Publikováno v:
Therapies. 66:347-354
Resume Les etudes realisees apres l’autorisation de mise sur le marche (AMM) ayant pour objectif d’identifier, caracteriser ou quantifier un ou des risques, appelees Post-authorization safety studies (PASS), ont ete renforcees ces dernieres annee
Autor:
Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, Alexandre Barna, Laurent Becquemont, Jean-François Bergman, Corine Bernaud, Isabelle Boucot, Isabelle Cheiney, Michel Cucherat, Anne d’Andon, Jérôme d’Enfert, Alain Francillon, Elisabeth Frauger, Danièle Girault, Jean-Marc Harlin, Alain Joseph, Catherine Lassale, Florence Mahlberg-Gaudin, Thierry Moreau-Defarges, Mira Pavlovic, Sophie Ravoire, Lise Rochaix, Eric Vicaut
Publikováno v:
Therapies. 65:329-334
Drug evaluation is based on comparison. Thus, the choice of the comparator for any new treatment becomes a key issue, especially when there are great differences in medical practice and of use conditions of the comparators depending on the geographic
Autor:
Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, Alexandre Barna, Laurent Becquemont, Jean-François Bergman, Corine Bernaud, Isabelle Boucot, Isabelle Cheiney, Michel Cucherat, Anne d’Andon, Jérôme d’Enfert, Alain Francillon, Elisabeth Frauger, Danièle Girault, Jean-Marc Harlin, Alain Joseph, Catherine Lassale, Florence Mahlberg-Gaudin, Thierry Moreau-Defarges, Mira Pavlovic, Sophie Ravoire, Lise Rochaix, Eric Vicaut
Publikováno v:
Therapies. 65:323-328
Resume La comparaison est un fondement de l’evaluation du medicament. Se pose des lors le probleme du choix du comparateur de tout nouveau traitement, ce d’autant plus qu’existent de larges disparites des pratiques medicales et des conditions d
Autor:
Alain Francillon, Gisèle Pickering, Chantal Belorgey, Michel Abiteboul, Bernard Bégaud, Jehan-Michel Behier, Bénédicte Chauvin, Antoine Cournot, Rémy Defrance, Jean-Paul Demarez, Élisabeth Devilliers, Vincent Diebolt, Bertrand Diquet, Yves Donazzolo, Muriel Echemann, Christian Funck-Brentano, Patrick Genissel, Nadine Houedé, Jean-Marc Husson, Philippe Lefevre, Isabelle Macquin-Mavier, Brigitte Marchenay, Christine Marey, Laurence Negres-Pages, Séverine Pitel, Valérie Plattner, Christine Roy, Michel Sibille, Nicolas Simon, Claire Thalamas, Dominique Tremblay, Tony Waegemans
Publikováno v:
Therapies. 64:155-159
The working group focused on defining exploratory trials on medicinal products and developing recommendations for their implementation in France (notably concerning non-clinical requirements, the pharmaceutical quality of the investigational medical
Autor:
François, Alla, Myriam, Rosilio, Christian, Funck-Brentano, Philippe, Barthélémy, Sophie, Brisset, Dominic, Cellier, Olivier, Chassany, Jean-Paul, Demarez, Vincent, Diebolt, Alain, Francillon, Laetitia, Gambotti, Hakima, Hannachi, Philippe, Lechat, François, Lemaire, Michel, Lièvre, Christophe, Misse, Marina, Nguon, Antoine, Pariente, Michel, Rosenheim, Nadine, Weisslinger-Darmon
Publikováno v:
Therapie. 68(4)
Autor:
Myriam Rosilio, François Alla, Nadine Weisslinger-Darmon, Olivier Chassany, Philippe Barthélémy, Hakima Hannachi, Christophe Misse, Philippe Lechat, Michel Rosenheim, Jean-Paul Demarez, Antoine Pariente, Vincent Diebolt, Michel Lièvre, Alain Francillon, Sophie Brisset, Marina Nguon, Christian Funck-Brentano, Dominic Cellier, Laetitia Gambotti, François Lemaire
Publikováno v:
Therapie. 68(4)
The development of medicinal products is subject to quality standards aimed at guaranteeing that database contents accurately reflect the source documents. Paradoxically, these standards hardly address the quality of the source data itself. The objec
Autor:
Florence Tubach, Véronique Lamarque-Garnier, Anne Castot, Laurent Auclert, Marthe Bonnin, Magda Daudin, Catherine Dubois, Alain Francillon, Elisabeth Frauger, Danièle Girault, Marie-Laurence Gourlay, Pascale Jolliet, Carmen Kreft Jaïs, Lamiae Grimaldi, Michel Lièvre, Patricia Maillère, Philippe Maugendre, Joelle Micallef, Sara Miranda, Antoine Pariente, Sylvie Paulmier Bigot, Jonathan Pentel, Laure Prestat, Fanny Pruvot, Valérie Querol Ferrer, Fanny Rocher, Christel Saussier, Laura Zanetti
Publikováno v:
Therapie. 66(4)
Studies conducted after the marketing authorisation with the objective of identification, characterization or quantification of one or more risks (called PASS "Post-Authorisation Safety Studies"), have been strengthened in the past years with the imp